Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer

Condition:   Bladder Cancer Intervention:   Drug: Durvalumab Sponsors:   Canadian Cancer Trials Group;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials